Pro Medicus's Renewals Dispelling AI-Disruption Fears -- Market Talk

Dow Jones
06/04

0454 GMT - Pro Medicus's latest contract renewal shows that customers are expanding usage rather than cutting deal lengths, RBC analyst Jackson Lee says. Some investors had worried that customers of companies including the Australian medical-imaging tech provider would try to shorten contracts to preserve the option of switching to AI-driven alternatives. However, Lee writes in a note that the A$16 million renewal with Ohio State University Wexner Medical Center was for an unchanged five years. The center is also taking up new product modules, he adds. RBC has a last-published sector perform rating and a A$195.00 target price on the stock, which is down 0.6% at A$158.74. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

June 04, 2026 00:54 ET (04:54 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10